Xiaozheng Kang

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

Wen‐Zhao Zhong, Ke‐Neng Chen, Chun Chen et al. · Journal of Clinical Oncology · 2019 · 267 citations

Medicine, Oncology, Pharmacology +15

Influence of Chemotherapy on <i>EGFR</i> Mutation Status Among Patients With Non–Small-Cell Lung Cancer

Hua Bai, Zhijie Wang, Ke‐Neng Chen et al. · Journal of Clinical Oncology · 2012 · 208 citations · Full text

Medicine, Oncology, Pharmacology +16

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Jianjun Qin, Liyan Xue, Anlin Hao et al. · Nature Medicine · 2024 · 196 citations · Full text

Medicine, Oncology, Pharmacology +14

Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases

Di Wang, Xiaohui Niu, Zhijie Wang et al. · Cancer Research · 2018 · 160 citations

Medicine, Genetics, Oncology +17

The high prevalence of knee osteoarthritis in a rural Chinese population: The Wuchuan osteoarthritis study

Xiaozheng Kang, Marlene Fransen, Yuqing Zhang et al. · Arthritis Care & Research · 2009 · 112 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12